BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18092133)

  • 1. Quantitative FDG-uptake by positron emission tomography in progressive hypertrophy of rat hearts in vivo.
    Handa N; Magata Y; Mukai T; Nishina T; Konishi J; Komeda M
    Ann Nucl Med; 2007 Dec; 21(10):569-76. PubMed ID: 18092133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeatable noninvasive measurement of mouse myocardial glucose uptake with 18F-FDG: evaluation of tracer kinetics in a type 1 diabetes model.
    Thorn SL; deKemp RA; Dumouchel T; Klein R; Renaud JM; Wells RG; Gollob MH; Beanlands RS; DaSilva JN
    J Nucl Med; 2013 Sep; 54(9):1637-44. PubMed ID: 23940301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative fluorine 18 deoxyglucose uptake by myocardial positron emission tomography in rats.
    Handa N; Magata Y; Tadamura E; Mukai T; Nishina T; Miwa S; Sakakibara Y; Nomoto T; Konishi J; Nishimura K; Komeda M
    J Nucl Cardiol; 2002; 9(6):616-21. PubMed ID: 12466786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraction of time activity curves from gated FDG-PET images for small animals' heart studies.
    Mabrouk R; Dubeau F; Bentourkia M; Bentabet L
    Comput Med Imaging Graph; 2012 Sep; 36(6):484-91. PubMed ID: 22658459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High intraindividual variability of global myocardial 18F-FDG uptake over time.
    Zöphel K; Kotzerke J
    J Nucl Med; 2008 Sep; 49(9):1570; author reply 1570-1. PubMed ID: 18703615
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
    Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
    J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of reversible trapping of tracer and the presence of blood metabolites on measurements of myocardial glucose utilization performed by PET and 18F-fluorodeoxyglucose using the Patlak method.
    Herrero P; Dence CS; Sharp TL; Welch MJ; Gropler RJ
    Nucl Med Biol; 2004 Oct; 31(7):883-92. PubMed ID: 15464390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 18F-FDG and 68Ga PET imaging in the assessment of experimental osteomyelitis due to Staphylococcus aureus.
    Mäkinen TJ; Lankinen P; Pöyhönen T; Jalava J; Aro HT; Roivainen A
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1259-68. PubMed ID: 16007423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can 18F-FDG-PET show differences in myocardial metabolism between Wistar Kyoto rats and spontaneously hypertensive rats?
    Quintana-Villamandos B; Delgado-Martos MJ; Fernandez-Riveira C; Fernández-Criado MC; Martos-Rodríguez A; Canillas F; Delgado-Baeza E
    Lab Anim; 2013 Oct; 47(4):320-3. PubMed ID: 23851029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial glucose metabolism in patients with hypertrophic cardiomyopathy: assessment by F-18-FDG PET study.
    Uehara T; Ishida Y; Hayashida K; Shimonagata T; Miyake Y; Sago M; Oka H; Nagata S; Miyatake K; Nishimura T
    Ann Nucl Med; 1998 Apr; 12(2):95-103. PubMed ID: 9637280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of myocardial 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy.
    Yamaguchi H; Hasegawa S; Yoshioka J; Uehara T; Hashimoto K; Kusuoka H; Kuzuya T; Hori M; Nishimura T
    Ann Nucl Med; 2000 Feb; 14(1):33-8. PubMed ID: 10770578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo quantitation of glucose metabolism in mice using small-animal PET and a microfluidic device.
    Wu HM; Sui G; Lee CC; Prins ML; Ladno W; Lin HD; Yu AS; Phelps ME; Huang SC
    J Nucl Med; 2007 May; 48(5):837-45. PubMed ID: 17475972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet.
    Kobayashi Y; Kumita S; Fukushima Y; Ishihara K; Suda M; Sakurai M
    J Cardiol; 2013 Nov; 62(5):314-9. PubMed ID: 23810066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal evaluation of left ventricular substrate metabolism, perfusion, and dysfunction in the spontaneously hypertensive rat model of hypertrophy using small-animal PET/CT imaging.
    Hernandez AM; Huber JS; Murphy ST; Janabi M; Zeng GL; Brennan KM; O'Neil JP; Seo Y; Gullberg GT
    J Nucl Med; 2013 Nov; 54(11):1938-45. PubMed ID: 24092939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of normal and infarcted rat myocardium using a combination of small-animal PET and clinical MRI.
    Higuchi T; Nekolla SG; Jankaukas A; Weber AW; Huisman MC; Reder S; Ziegler SI; Schwaiger M; Bengel FM
    J Nucl Med; 2007 Feb; 48(2):288-94. PubMed ID: 17268027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
    Park SI; Lee JH; Ham HJ; Jung YJ; Park MS; Lee J; Maeng LS; Chung YA; Jang KS
    Biomed Mater Eng; 2015; 26 Suppl 1():S1669-76. PubMed ID: 26405933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
    Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK
    J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial energetics is not compromised during compensated hypertrophy in the Dahl salt-sensitive rat model of hypertension.
    Tran K; Han JC; Taberner AJ; Barrett CJ; Crampin EJ; Loiselle DS
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H563-71. PubMed ID: 27402668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the relationship between physiological FDG uptake in the heart and age, blood glucose level, fasting period, and hospitalization.
    Kaneta T; Hakamatsuka T; Takanami K; Yamada T; Takase K; Sato A; Higano S; Kinomura S; Fukuda H; Takahashi S; Yamada S
    Ann Nucl Med; 2006 Apr; 20(3):203-8. PubMed ID: 16715951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.